A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer
Junji Furuse, Takuji Okusaka, Shinichi Ohkawa, Michitaka Nagase, Akihiro Funakoshi, Narikazu Boku, Kenji Yamao, Taketo Yamaguchi, Toshiya SatoVolume:
65
Language:
english
Pages:
8
DOI:
10.1007/s00280-009-1011-z
Date:
December, 2009
File:
PDF, 324 KB
english, 2009